New + Emerging Treatments

The New + Emerging Treatments conference is hosted by the Leukemia Research Foundation for leukemia patients, caregivers, family members, and healthcare professionals. Each hour-long webinar is dedicated to a specific subtype of leukemia, discussing the latest treatments and what's on the horizon, followed by a Q + A.

The virtual conference programs are Tuesday, June 11 and Wednesday, June 12.  Participants can register for one or multiple sessions.

Farrukh Awan - 200x250 - 2 - best

Chronic lymphocytic leukemia (CLL)

Tuesday, June11, 2024 i 7:00PM-8:00PM CT  (5-6 PT, 6-7 MT, 8-9 ET)

Farrukh T. Awan, MD, from the Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, will discuss current CLL treatments and what new treatments are on the horizon.

Gabby Hobbs - 200x250

Chronic myeloid leukemia (CML)

TUESDAY, JUNE 11, 2024 I 8:00-9:00 CT  (6-7 PT, 7-8 MT, 9-10 ET)

Gabriela Hobbs, MD, Clinical Director of the Adult Leukemia Service Program, from Massachusetts General Hospital, will discuss current CML treatments and what new treatments are on the horizon.

Shira Dinner - 200x250

Wednesday, JUNE 12, 2024 I 7:00-8:00PM CT  (5-6 PT, 6-7 MT, 8-9 ET)

Shira N. Dinner, MD, from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Feinberg School of Medicine, will discuss current ALL treatments and what new treatments are on the horizon.

Matt Christopher - 200x250- close-up

Acute myeloid leukemia (AML)

Wednesday, June 12, 2024  |  8:00-9:00pm CT (6-7 PT, 7-8 MT, 9-10 ET)

Matt Christopher, MD, PhD, from the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, will discuss current AML treatments and what new treatments are on the horizon.

Program supporters

Abbvie logo - 221x60
Astellas logo - resized
Kite - 221x60
Merck - 221x60
Novartis - 221x60
Pfizer 221x60